Bioserenity (original) (raw)
BioSerenity is medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases such as epilepsy. The medical devices are composed of medical sensors, smart clothing, a smartphone app for Patient Reported Outcome, a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.
Property | Value |
---|---|
dbo:abstract | BioSerenity is medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases such as epilepsy. The medical devices are composed of medical sensors, smart clothing, a smartphone app for Patient Reported Outcome, a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics. (en) BioSerenity est une startup française fondée en 2014 qui fournit des solutions de diagnostic et de monitoring des patients, allant de la capture des données via des dispositifs médicaux connectés tels que le Neuronaute et le Cardioskin, jusqu'à l'analyse des données via des outils d'intelligence artificielle permettant l'identification automatique de biomarqueurs numériques et des professionnels de la santé. La société s'est d'abord concentrée sur la Neurologie, avant de s'étendre aux troubles du sommeil et à la cardiologie. (fr) |
dbo:foundingDate | 2014-01-29 (xsd:date) |
dbo:foundingYear | 2014-01-01 (xsd:gYear) |
dbo:numberOfEmployees | 400 (xsd:nonNegativeInteger) |
dbo:wikiPageExternalLink | https://www.bioserenity.com/ https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm%3FID=K110486 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm%3FID=K170138 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm%3FID=K173248 |
dbo:wikiPageID | 68692311 (xsd:integer) |
dbo:wikiPageLength | 10435 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID | 1108861115 (xsd:integer) |
dbo:wikiPageWikiLink | dbr:Epilepsy dbc:Health_care_companies_established_in_2014 dbr:Patients dbc:Machine_learning dbc:French_companies_established_in_2014 dbc:Healthcare_companies_of_France |
dbp:areaServed | US, France, China (en) |
dbp:founded | 2014-01-29 (xsd:date) |
dbp:founder | Pierre-Yves Frouin (en) |
dbp:locationCity | Paris (en) |
dbp:locationCountry | France (en) |
dbp:name | BioSerenity (en) |
dbp:nativeNameLang | fr (en) |
dbp:numEmployees | 400 (xsd:integer) |
dbp:numEmployeesYear | 2019 (xsd:integer) |
dbp:owner | IDinvest Partners, LBO France, BPI, Dassault Systemes, Innothera, SCOR (en) |
dbp:products | Neuronaute, Cardionaute, Cardioskin (en) |
dbp:services | Neurophy, Cardiophy, Somnophy (en) |
dbp:type | Privately held company (en) |
dbp:website | https://www.bioserenity.com/ |
dbp:wikiPageUsesTemplate | dbt:Authority_control dbt:Infobox_company dbt:Short_description dbt:Start_date dbt:Use_mdy_dates |
dct:subject | dbc:Health_care_companies_established_in_2014 dbc:Machine_learning dbc:French_companies_established_in_2014 dbc:Healthcare_companies_of_France |
rdf:type | owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation |
rdfs:comment | BioSerenity is medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases such as epilepsy. The medical devices are composed of medical sensors, smart clothing, a smartphone app for Patient Reported Outcome, a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics. (en) BioSerenity est une startup française fondée en 2014 qui fournit des solutions de diagnostic et de monitoring des patients, allant de la capture des données via des dispositifs médicaux connectés tels que le Neuronaute et le Cardioskin, jusqu'à l'analyse des données via des outils d'intelligence artificielle permettant l'identification automatique de biomarqueurs numériques et des professionnels de la santé. La société s'est d'abord concentrée sur la Neurologie, avant de s'étendre aux troubles du sommeil et à la cardiologie. (fr) |
rdfs:label | Bioserenity (en) BioSerenity (fr) |
owl:sameAs | wikidata:Bioserenity dbpedia-fr:Bioserenity https://global.dbpedia.org/id/Budyx |
prov:wasDerivedFrom | wikipedia-en:Bioserenity?oldid=1108861115&ns=0 |
foaf:homepage | https://www.bioserenity.com/ |
foaf:isPrimaryTopicOf | wikipedia-en:Bioserenity |
foaf:name | BioSerenity (en) |
is dbo:wikiPageWikiLink of | dbr:Electroencephalography |
is foaf:primaryTopic of | wikipedia-en:Bioserenity |